Month: January 2023

The hospitals are asking a judge to deny OHA’s motion to dismiss. Click here to view original post

BeiGene CEO John Oyler and Endpoints News Executive Editor Drew Armstrong spoke one-on-one about where the drugmaker is headed in its quest to become a diversified multinational, and what it will take to get there. […]

The increase in the impact of western culture, rapid urbanization, changes in consumers’ perception toward the consumption of alcohol-based food products, and change in consumer preferences in the developing regions drive the global Manuka Honey […]

The improving pharmaceutical industry, rise in unmet industry needs, and surge in the demand for accurate weighing balances drive the growth of the global Laboratory Balances And Scales market. PORTLAND, Ore., Jan. 27, 2023 /PRNewswire/ […]

He replaces Phil Bosua, who has led the Seattle-based public company as CEO since 2018. Click here to view original post

The Washington-based CDMO AGC Biologics has been tapped to manufacture the type 1 diabetes treatment Tzield from Provention Bio. AGC Biologics will produce Tzield at its Seattle protein biologics site. It was chosen after AGC […]

Surge in prevalence of diabetes in pet animals, and growing pet adoptions drives the growth of the global Pet Diabetes Care Devices market. PORTLAND, Ore., Jan. 26, 2023 /PRNewswire/ — A new business intelligence report […]

There were 25 deals valued at $73 million in region last year. Click here to view original post

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the shipments of the first products from […]

Researchers measured the immune response in blood samples from 96 generally healthy OHSU employees. Click here to view original post